DEFA14A ·Filed Apr 21, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine shareholder meeting with no material financial impact. Monitor for any unexpected outcomes in the director elections or auditor ratification.
Final — all horizons settled through T+60d ⚠ clustered
BIOA ▲ +24.24% at T+60d
NEUTRAL call ✓ call won +24.24% · α vs SPY +19.46% · entry $18.36 → $22.81
T+1d
-6.10%
call -6.10% · α -5.71%
$17.24
settled 5mo ago
T+5d
-6.64%
call -6.64% · α -6.70%
$17.14
settled 5mo ago
T+20d
-10.84%
call -10.84% · α -14.00%
$16.37
settled 5mo ago
T+60d
+24.24%
call +24.24% · α +19.46%
$22.81
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
BioAge Labs, Inc. is holding its 2026 annual meeting to elect three Class II directors and ratify the appointment of KPMG LLP as its independent registered public accounting firm. The board recommends voting FOR both proposals.
Key Facts
- BioAge Labs, Inc. is holding its 2026 annual meeting on June 10, 2026.
- The meeting will be held virtually via the internet.
- Shareholders of record as of April 16, 2026 are eligible to vote.
- Proposal 1 is to elect three Class II directors: Patrick Enright, James I. Healy, and Rekha Hemrajani.
- Proposal 2 is to ratify the appointment of KPMG LLP as the independent registered public accounting firm for 2026.
- The board of directors recommends voting FOR both proposals.
- The company has recently seen insider selling of $157K.
Financial Impact
Routine corporate governance matters with no immediate financial impact.
revenueepsdebt
Risk Factors
- Potential for shareholder dissent on director elections.
- Risk of auditor change if KPMG is not ratified.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-166751 |
| Document: 0001193125-26-166751-index-headers.html | 0001193125-26-166751 |
| Document: 0001193125-26-166751-index.html | 0001193125-26-166751 |
| Document: 0001193125-26-166751.txt | 0001193125-26-166751 |
8 reports for BIOA
50% Hit rate best @ T+60▲ +13.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 16, 2026 15w ago | Press Release | $20.49 $8.65 | ▼ −57.78% | ▼ −58.78% | $6.72 (−67.20%) |
May 8, 2026 21w ago | 8-K | $17.99 $11.20 | ▼ −37.74% | ▼ −42.58% | $6.72 (−62.65%) |
Apr 21, 2026 23w ago | DEFA14A | $18.36 $22.81 | ▲ +24.24% | ▲ +19.46% | $6.72 (−63.40%) |
Apr 21, 2026 23w ago | Press Release | $19.61 $22.16 | ▲ +13.00% | ▲ +6.10% | $6.72 (−65.73%) |
Apr 1, 2026 26w ago | 144 | $17.73 $24.95 | ▲ +40.72% | ▲ +27.34% | $6.72 (−62.10%) |
Mar 24, 2026 27w ago | Press Release | $16.11 $20.77 | ▲ +28.93% | ▲ +14.60% | $6.72 (−58.29%) |
Mar 2, 2026 30w ago | Court Ruling | $21.71 $16.95 | ▼ −21.93% | ▼ −31.26% | $6.72 (−69.05%) |
Feb 28, 2026 30w ago | Institutional Cluster | $21.71 $16.20 | ▼ −25.38% | ▼ −34.71% | $6.72 (−69.05%) |
Showing 8 of 8
US Market Status
Market Open — Closes in 5h 35m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access